Abacus Global Management, Inc. (ABX) Earnings Call Transcript & Summary
November 5, 2026
Earnings Call Speaker Segments
David Jackson
executiveThank you, operator, and I appreciate everyone joining us for Abacus Global Management's Third Quarter Earnings Call. With me today are Jay Jackson, our Chairman and Chief Executive Officer; Elena Plesco, our Chief Investment Officer; and Bill McCauley, our Chief Financial and Chief Operating Officer. Earlier this afternoon, at 4:05 p.m. Eastern Time, Abacus Global Management released its third quarter 2026 results. During today's call, participants will have an opportunity to ask questions about those results. Before we begin, Abacus Global Management points participants to the Investor web page, ir.abacusgm.com, where the press release, investor information and SEC filings are posted, including a discussion of the risks that can affect the business. Abacus Global Management directs participants specifically to the presentation it filed today on Form 8-K with the Securities and Exchange Commission, and reminds listeners that certain remarks made today might include forward-looking statements, which would therefore be subject to risks and uncertainties that, should they materialize, could materially affect results. For additional details regarding the risks, uncertainties and assumptions connected to forward-looking statements, please consult Abacus Global Management's public filings. On this call, we will cite certain non-GAAP financial measures. While we believe these measures offer useful supplemental information concerning our financial performance, they are not recognized measures and lack standardized meanings under U.S. generally accepted accounting principles, or GAAP. For further details on our non-GAAP financial measures, including how they compare to GAAP figures, please refer to our public filings. With that, I'll hand the call over to Jay Jackson, Chairman and Chief Executive Officer of Abacus Global Management.
Jay Jackson
executiveThank you, David, and thanks to everyone for being with us today. Abacus had a momentous third quarter. We delivered operational outperformance and achieved meaningful strategic progress. During Q3 by itself, we held our Investor Day at the New York Stock Exchange, introduced the ABX Longevity Growth and Income Fund, and closed the biggest securitization we have ever done. More recently, we expanded LifeARC's reach via our partnership with Retirable and its RIA network, working alongside Manning & Napier. Let me begin with several key metrics that Bill and Elena will cover in more detail later. Through Q3, inflows to the longevity fund reached $997 million, versus $604 million for the entirety of 2025. Outside purchasers are still showing robust appetite for what we own, and the money we make continues to turn into actual cash. Over the last twelve months, cash EBITDA reached $203.2 million — that works out to 132% of adjusted EBITDA — because gains we booked in prior periods converted to cash faster than we generated fresh ones. The gains on our books are turning into real money, and that gives solid backing to how we value our portfolio; during this quarter, 2 of our funds, which together hold more than $1 billion in AUM, offloaded 27% of their portfolios to investors at prices above NAV. In other words, outside buyers are paying more than the carrying values we assign, which is the toughest validation of our marks that we have. Still, the development I'd most like you to remember from this quarter is LifeARC. In the coming decades, roughly $124 trillion is projected to move between generations within the United States. Almost all the financial planning underlying that wealth continues to resolve its central question by estimation. What will my lifespan be? Human longevity follows a curve of likelihoods, and LifeARC stands as the inaugural platform designed to quantify that curve for a single person. We're taking the proprietary longevity data and HIPAA-compliant medical insight that we've built over more than 20 years for institutional markets and making it available to individual investors and the advisers who work with them. That is why Abacus sits at the heart of how this wealth transfer is going to be planned and managed. We are still at an early stage, yet the initial signals are remarkable. To date, LifeARC has produced 357 inquiries. During just the first week of our new client pipeline, those inquiries accounted for approximately $43 million in combined investable assets — roughly $7 million on average per inquiry, and the largest came in at $20 million. The pipeline has so far encompassed more than $500 million in investable assets. Those who are approaching LifeARC are precisely the people we designed it for. 91% are 50 or older, with an average age of 66, and 100% chose to be contacted. The tools are performing exactly as we intended. Out of the first seven pipeline inquiries, six arrived via our lifespan calculator, and we've already recorded our initial referral flow from abacusgm.com into LifeARC. Two partner firms, Retirable and Manning & Napier, are now live and enrolling clients into LifeARC investment portfolios. Following the October 13 announcement of that partnership, LifeARC has ranked #1 on Google for its name, and branded search clicks rose fivefold in a single week. On the funding side, our latest securitization closed in September, with a total structure exceeding $400 million. That transaction is our largest securitization to date, and it's roughly 8x the size of our inaugural note from only a year ago. Insurance companies took the bulk of those investment-grade rated notes. Demand ran twice the size of the offering, so we were able to increase the deal. Because this was a rated transaction, the assets went through stress testing and got reviewed by prominent institutional financial sponsors as well as insurers managing hundreds of billions of dollars; we treat that as validation from the market and a valuable new capability in our toolkit. Securitization represents one more route for widening our distribution channels, and it delivers an advantage in cost of capital along with greater efficiency as we expand. We're not providing a dollar target, but we expect to complete two to three securitizations per year, with the following one currently planned for Q1 of 2027. What Abacus is turning into really came through this quarter: a platform where over 20 years of longevity data drives institutional capital markets on one side and individual financial planning on the other. Our confidence is high that this momentum can carry on through the quarters and years to come. With that said, I'll hand the call to Bill so he can walk through our quarterly financials.
William McCauley
executiveThanks, Jay. Just like in previous quarters, I'll begin with the outlook and then go through how we performed operationally and financially. Adjusted net income for the third quarter was $29.4 million, which exceeded the upper bound of the $26 million to $28 million guidance range we provided last quarter. Given that robust result, we're lifting our full year 2026 guidance for the second time this year. We now anticipate adjusted net income between $104.5 million and $106.5 million, raised from $100 million to $106 million; and adjusted EPS of $1.05 to $1.07, raised from $1 to $1.05. At the high end, that's 24% growth compared with 2025. For the fourth quarter, our expectation is adjusted net income of $28 million to $30 million, or adjusted EPS of $0.28 to $0.30, and at the top end that equals 30% growth versus the fourth quarter of 2025. As a reminder, our adjusted net income guidance is shown on a gross basis, before estimated tax effects. Jay put it well. Momentum at Abacus is still strong across a widening set of value-creation opportunities; during the third quarter we put $235.3 million of capital to work, bringing the year-to-date figure to $596.8 million, a 71% increase over our 2025 pace. In Q3 we examined 17,787 qualified policies, and year-to-date the count of policies reviewed now exceeds 101,000. Consistent with what we said last quarter, Abacus keeps improving inbound volume at the top of the funnel and has also made screening and underwriting more efficient using technology and AI. Demand was strong as well for our longevity fund products, with capital inflows reaching roughly $452.4 million in the third quarter, more than 6x the pace of the same period a year earlier. Now to our financial results. Abacus brought in revenue of $76.9 million for the third quarter, a 22% rise year-over-year. That growth came from Life Solutions revenue of $71.3 million, up 32% from $54.1 million a year ago, along with Technology Services revenue of $0.6 million, up 155% from $0.2 million a year ago. Within the Life Solutions segment, growth was powered by strong performance on life settlement policies sold. To be specific, realized gains on policies sold and matured increased by $25.8 million year-over-year, more than offsetting an $11.1 million drop in unrealized gains. Abacus also delivered strong growth in both insurance commissions and on originations, which rose 145.5% and 281.9%, respectively, versus a year ago. Operating expenses for the third quarter came to $43.4 million, driven by general and administrative expenses of $33.6 million, up from $24.7 million, and sales and marketing expense of $5.6 million, up from $3.8 million. The 32% increase in total operating expenses was mostly the result of higher legal and professional fees. G&A came in higher by $8.9 million, largely because we saw $5.2 million more in legal and professional fees tied to a range of strategic projects, plus $1.8 million in added payroll from staff brought on through acquisitions. Sales and marketing, meanwhile, increased $1.8 million, reflecting heavier advertising spend to back growth in Life Solutions. Adjusted EBITDA for the quarter reached $42.3 million — a 55% margin — and that is still quite robust even with the professional fee step-up I just referenced. Year-over-year, adjusted EBITDA climbed 12%, powered by strong Life Solutions growth and partly offset by reduced asset management fees and the higher professional fees. Consequently, adjusted net income for the third quarter rose 24% versus a year ago, landing at $29.4 million, equivalent to adjusted EPS of $0.29. Our adjusted return on equity stood at 26%, a gain of 440 basis points year-over-year. We finished the quarter with $104 million in cash alongside policy assets of $370 million. As the presentation points out, we feel great about how much faster cash conversion from EBITDA has become. So far this year, each dollar of adjusted EBITDA has produced $1.46 in operating cash flow. Excluding nonrecourse liabilities, long-term debt now sits at $366 million. On the whole, Abacus has a strong balance sheet, and it gives us a platform to grow and build shareholder value in several ways; beyond funding growth from LifeARC and our expanding partnerships, Abacus has also given capital back to shareholders via buybacks and dividends. In August, the Board approved a $100 million repurchase authorization running through May 2028. During the quarter, we bought back $1.7 million of ABX shares at an average price of $8.13. We are also glad to report that the Board unanimously signed off on raising our regular annual dividend by 10%, to $0.22 per share, with an ex-dividend date of December 1, 2026. In sum, both our results and our outlook keep showing strong growth and momentum behind our strategy. And as Jay noted, we are enthusiastic about what is coming next for Abacus. With that, I will hand the call to Elena, who will walk through our balance sheet performance and investment strategy.
Elena Plesco
executiveBill, thanks. There are three items I want to cover this quarter: first, a review of how the balance sheet performed; second, the completion of our landmark $400 million securitization and its significance; and third, the unit economics of every distribution channel and the direction we're taking the business. Starting with the balance sheet: annualized portfolio turnover for the third quarter reached 3x, which is above our long-term target range of 1.5 to 2x. Such a turnover level shows sustained demand for the assets we originate as well as our capacity to recycle capital efficiently, all while maintaining our underwriting discipline. During the quarter we put roughly $235.3 million of capital to work, a 130% increase from a year earlier, and that signals both strong origination volume and solid investor appetite. For the quarter, our average realized gain on policy sales came in at about 24%, which is comfortably ahead of the 20% plus long-term target we've set. I'd like to emphasize what that figure actually means, since it sits at the heart of how we view this business. These represent completed transactions at genuine prices with genuine counterparties. On an annualized basis, our book turned 3x this quarter. Turnover is going to fluctuate quarter to quarter, but what we're talking about is actual cash realized, not screen marks. Each time the book turns, it confirms the fair value we carry. There's a lot of debate right now about whether private asset marks are real, and in that kind of market, this distinction matters—I'll return to it. Another way we gauge efficiency is holding period. The policies we sold during this quarter had an average holding period of roughly 62 days, compared with about 212 days for the policies still on our balance sheet; the main reason is that we recycled capital late in the quarter because of how the securitization was timed. Let me now move to our most recent securitization, which closed in September, was a defining event for the quarter, and is setting the direction for our business. Our goal there was to broaden the ways we distribute what we originate. Think of our balance sheet as a warehouse: we create policies, keep them while they mature, and then sell them off — that's why turnover matters so much to us. We've always concentrated on developing the channels on the far side of that warehouse, and securitization is the latest one. It provides a substantial, cheaper source of capital, together with institutional sales and our funds, scaled to match the $235.3 million of origination during the quarter; we moved longevity assets into a special purpose vehicle and issued investment-grade rated Class A and Class B notes, placed privately mainly with insurance companies. The whole structure, residual included, exceeds $400 million. That comes to about eight times what our first $50 million note was in October 2025. There was more demand than the deal could absorb, which let us increase its size. Abacus keeps part of the residual interest and continues as servicer. I'd highlight four ways this contributes to each rotation of our flywheel. Cheaper funding: every dollar of equity backs more origination when we issue investment-grade notes. Faster recycling: as more channels perform reliably, capital can be turned over sooner, and the proceeds go straight back into origination. With a book that turned 3x this quarter, that compounds. Recurring income: we stay on as servicer and hold onto the residual. So the economics remain with Abacus well past the sale. I'll get to that figure shortly. New buyers: insurers and other fixed income purchasers now have a rated way into this asset class, which unlocks a deep pool of capital that previously had no practical entry point. There's also a validation element here I don't want to play down. An investment-grade rating means independent agencies examined the collateral along with our origination and servicing platforms and felt comfortable rating the notes. The purchasers were insurance companies, among the most conservative capital in the market. Compare that with a book that converts its marks into cash, and you get roughly the strongest outside validation of our asset values you could hope for. Securitization additionally expands our servicing platforms, which currently encompass 3,905 policies and $8 billion of face value. We intend this to be a repeatable channel rather than a one-time event. I'd like to spend a moment on channel economics now, since they clarify where the business is heading better than any target could; we distribute what we originate via 3 channels: institutional sales since 2004, managed funds since 2023, and securitization since 2025. All 3 are priced within a single framework. So the upfront gain we make is unchanged from what it has historically been—20% to 25% on a gross basis—regardless of which channel the policy is placed into. The difference lies in what comes afterward. With institutional sales, that upfront gain is all there is: it's a single transaction with no ongoing fees, and any upside belongs to the buyer. With longevity funds, if that same policy is placed into one of our funds, we still make that identical upfront gain. On top of that, we received 75 to 100 basis points annually in management and servicing fees calculated on the fund AUM, as well as performance fees over hurdle rates. With securitization, we again make that same upfront gain, and additionally 50 to 100 basis points per year on portfolio value. We also retain a residual interest that gets paid after the noteholders do. Based on how a given structure is set up, we aim for that residual to land in the teens when measured on an IRR basis. So when the same asset is originated once and priced once, it carries meaningfully greater value for us inside a fund or a securitization than it would in a wholesale trade. That's the driver behind our shift in mix. Our goal of reaching 70% fee-related revenue by 2030 isn't the reason we're making this change. It's the outcome of routing a larger share of what we originate into channels that compensate us more, for longer, while using less balance sheet capital. Fee-related revenue currently makes up only about 11% of our mix, and each securitization and each fund dollar pushes that figure upward. Our approach hasn’t changed: we operate a distinctive origination platform, apply rigorous underwriting, and monetize consistently; and we are shifting a greater share of what we originate into the channels that offer the strongest economics. Those are the priorities we set out at Investor Day, and during the third quarter we made genuine progress on them. So with that, I’ll hand it back to Jay for a few closing remarks.
Jay Jackson
executiveThank you, Elena. Before we get to your questions, there's one key point I want to stress for our investors and analysts. Obviously, our enthusiasm remains greatest when it comes to LifeARC's breadth and its potential over the long term. We genuinely believe Abacus will keep widening and compounding the value use cases that our data and platform are able to produce. Along those lines, the quarter just ended offers yet another strong illustration of the steady drumbeat of proof points Abacus is gaining in the market — whether through new financial service partnerships such as Retirable, or through meaningful scaled investment from institutional capital in our $400 million securitization. We're excited for our shareholders. The long-term value proposition of our stock is massive. We certainly believe it. But what feels especially rewarding is providing frequent evidence that supports that belief as we keep issuing press releases and reporting quarterly results. Thank you again for joining us, and we'll now take your questions.
Patrick Davitt
analystI realize it's still early, but with the political change coming in D.C., I'm curious whether you know of any Democratic priorities likely to receive more attention now that could help or hurt your business.
Jay Jackson
executiveAbsolutely. Thanks, Patrick. A few things come to mind. First, I believe we're all quite aware that gridlock in D.C. isn't such a bad thing for — broadly speaking on the regulatory front, not much will be accomplished. That said, if you look at it from the angle of which Democratic positions might affect us, what's interesting is how they'll handle the estate tax. If they attempt to undo any elements of the Big Beautiful bill that had lifted the estate tax threshold for overall net worth requirements, should that occur and they somehow manage to push it through and bring that level down, that would actually result in more insurance policies likely being sold, because people would then seek to bridge that estate tax planning gap with additional insurance contracts, which over the long term could benefit what we do in acquiring those contracts afterward. Beyond that, though, from a regulatory standpoint, we're positioned really well no matter which party is in power. And this even traces back to the previous administration, when we saw no truly meaningful regulatory changes affecting our industry or the underlying contracts we acquire; and we expect a reasonably favorable road ahead regarding future regulation simply because it's such a positive transaction for the underlying client.
Patrick Davitt
analystGreat. Good to hear; and the ABX Longevity Growth and Income Fund has now been on the market for a few months. Could you update us on the distribution plan for that product? And to the extent you can, any pipeline for new platform adoption and/or how initial uptake is tracking with platforms that are already selling it?
Jay Jackson
executiveSure. The ABX is — Longevity Growth and Income Fund is our interval fund product with a ticker, public fund. We've made significant progress in getting that onto a number of platforms. A few platforms lean more heavily on time requirements, with Schwab being the main driver of that, while others don't impose such a time condition—they're looking for a one-year track record. Given that, we've been engaging directly with several large RIAs that we already source and serve in the life insurance business, which has been a great corollary for us in discussing this particular fund with them. And all in all, the response has been outstanding. We expect to begin seeing some interesting flows into that product in Q1. Beyond that, I'd note that pension funds and major financial institutions are examining this offering closely too, since it provides an additional route to our asset without the usual closed-end GP/LP fund arrangements. So progress has been substantial. Strong distribution is being brought on right now, which is the reason I brought it up near the close of my remarks this evening.
Timothy D'Agostino
analystThis came up on the conference call for last quarter, but I spotted it once more. Regarding the fees on AUM, when I look at our model, it appears to have dipped from one quarter to the next. I suppose, could you give a bit more detail on that? Is it like what we saw last quarter, when, as I recall, it was simply more flows going into ETFs, or is there anything else — any additional detail on the quarter-over-quarter change would be useful.
Jay Jackson
executiveCertainly; and yes, I'm happy you raised that question; and the interesting thing about this quarter on those, we expect them to begin moving in the next — in the opposite direction, heading back up, as we come into Q4 and Q1; we view this as a quarter in which we had certain onetime adjustments, tied specifically to some closed-end funds that were approaching the end of their maturation. And so, for that reason, we were — we essentially saw a onetime sort of adjustment in that area. And then, that adjustment, I believe, will shift back the other way as we come into the following quarter. And specifically, when you consider the securitizations, adding that securitization will begin to affect those fees too. So I'm aware there were a couple of sort of back-to-back items with the ETFs pulling some things down, and then we had a couple of adjustments stemming from certain funds, especially our offshore funds, and those adjustments will be reconciled, or in effect, you'll begin to see that trend reverse in Q4 and Q1.
Timothy D'Agostino
analystAll right. And if I could follow up with one more question. Regarding buybacks, could you give a bit more detail on how you decide the amount you repurchase during the quarter? I'm trying to get a sense of what would make you want to buy back more rather than less.
Jay Jackson
executiveCertainly. As for the stock, when we consider buybacks or repurchasing our shares, for us it's a fairly simple, straightforward calculation. We compare it with our ROI and ROE, whether from the prior quarter or what we have at that moment. And as you'll see, our ROE on policies is quite high. I believe it was above 26%; and when you weigh that against buying stock, it comes down to — do we see 26% upside in the stock? Of course, we do. We see far more than that, just as I think you do. It's closer to 50-plus-percent; so that's basically the math behind it. But we also try to balance how much capital we have against the buyback. So when we look at the buyback, we'll say we want to stay in the market and make sure we aren't affecting the market in terms of the volume of stock traded that day. And then we simply gauge that by where the average purchase price sits. I think in the filings, we discussed where the buyback prices were. And typically, you'll see us historically around that low-$8 price; and in some cases, I think our historical number is below $8; so if you're looking at perhaps a signal of where we've historically been buying, it tends to be in the very low-$8 or even sub-$8 range, and it makes a lot of sense for us to acquire the stock.
Andrew Kligerman
analystNice work on that securitization. I'm just a bit curious — for the Class A and Class B notes, what are the durations of each? And on the residual side, how much capital has Abacus deployed there?
Elena Plesco
executiveAndrew, it's Elena here. Regarding the Class A and Class B notes, under the base case the weighted average life is expected to come in at sub-5 years for both; the legal final maturity, though, runs beyond 20 years. So if we don't — if we choose to hold until the final asset gets repaid in a more stressed scenario, that capital is fully duration matched, which is pretty handy.
Andrew Kligerman
analystGot it. And what about the capital tied up in the residual?
Elena Plesco
executiveThat residual portion comes to 15%.
Andrew Kligerman
analystAll right, understood. All right. Now turning to Manning & Napier, might you provide a few metrics regarding some of the fresh business they are generating with Abacus products, be it the funds or the life insurance offerings?
Jay Jackson
executiveCertainly. Manning & Napier is an outstanding firm, as we have mentioned before, holding more than $18 billion in assets under management across both their RIA and their investment funds. We structured that partnership so it would deliver essentially 3 distinct synergy areas. The first was sourcing policies from their clientele. To be specific, we monitor how many policies their clients have now committed to potentially buy through us, and the response has been remarkable. I believe simply making that client base aware that this financial option is available to them generates the flywheel we referenced, since the next synergy area with Manning is that once we purchase that contract, the new capital we pay out for their policy returns to the client account as assets under management. And as — you are now witnessing growth, or the potential for positive feedback leading to growth, of AUM at Manning and Napier, because that client holds greater liquidity in their accounts to invest. After that, the third area involves fund distribution. Their clients — particularly when we consider it, our interval fund suits that purpose well. Thus, those clients can either redeploy part of that money into an asset that has just given them added liquidity, or there are even other clients who are merely looking for assets that are less correlated and less volatile than what they may hold, especially given the kinds of markets we face today. So we are observing this across 3 areas: sourcing new policies. We are observing it in greater lead generation for new financial advisory clients; and then, we are observing distribution of Abacus' funds across their platform.
Andrew Kligerman
analystSo all three of those areas are showing impact?
Jay Jackson
executiveYes, and it hasn't taken long. Only a few months have passed since we made our initial announcement earlier this year, and we're already seeing impacts in real dollar amounts. Also keep in mind that LifeARC is a program involving financial planning based on lifespan and asset allocation based on lifespan, and that really will fundamentally change the way retirees allocate assets in retirement, right? If their number one fear is running out of money in retirement, shouldn't they know how long their retirement is going to last? And that lead gen is bringing in new leads for Manning & Napier. Beyond that, this will also produce extra asset allocation models, since at age 65 most individuals shift to conservative holdings very fast. Here, it motivates them to stay in equities and alts. As a result, they now possess concrete evidence on which to base the choice: look, my projected lifespan could exceed 22 years, so you ought to hold equities, you ought to hold alts, and you ought to keep your money working longer rather than moving into a highly conservative bond portfolio yielding less. Here, you can boost your retirement income simply by knowing that fundamental figure. Manning & Napier is in the process of deploying LifeARC right now — that rollout is underway at this very moment.
Crispin Love
analystAbout the securitization — I suppose the appealing long-term economics and the recurring fees — but can you tell us how much the securitization added to earnings or EPS this quarter, and what that onetime gain amounted to?
Jay Jackson
executiveRight, we aren't disclosing the onetime gain, nor the gain tied to the securitization. Still, I believe it clearly showed up in our capacity to put capital to work, correct? And I'd call that one KPI. Crispin, as you and I have discussed, this relates to how much capital gets deployed in any given quarter. Historically, that figure ran from $100 million to $140 million. Then this year we set our sights on $130 million up to perhaps even $150 million, $160 million; and this quarter, we deployed $230 million. So once you begin to see how we can do that while still having a considerable amount of cash arriving in Q4, I think that matters a great deal when you consider what the securitization accomplishes, because, as Elena emphasized, it's a velocity of capital. And with that velocity of capital, you saw the book turn rise; so another KPI area I'd highlight is that you now have 3x on the turn annually; and ultimately, what happens is, as we move into — as successful as the securitization was, we're already examining the next one and aiming for 2 to 3 a year and perhaps even more, but our target is 2 to 3 per year. You can see how that will affect growth and earnings. Yet at the same time, it's — in my view, this is a way that means our earnings become, I believe, quite consistent and stay consistent, exactly as they have been for the last 2 years. So from where we sit, the KPI I think deserves attention here is that you're seeing capital deployed go up, you're seeing turns go up, which in the end affects EPS positively.
Crispin Love
analystThanks — that was really thorough. Now, on Slide 11, you showed the way revenue mix changes through 2028 — Life Solutions getting to 40%, Asset Group at 30%, and so on, as I recall. When we talked about this about a year back, Life Solutions was up somewhat, moving from 84% to 89%. That obviously shows things are going well in Life Solutions, though the asset management side is a little less clear. So I'd like to know if you could break down what's driving the change in that mix. Is it securitizations, fee revenues, AUM? I'm just wondering how you're approaching that.
Jay Jackson
executiveYes. I think we'll see this mix shift in a couple of ways, especially as we look ahead to '27 and '28. You've hit the nail on the head. The success of Life Solutions affected the percentage increases tied to asset management, and that isn't a bad thing, right? That's something all of us should take pride in as we continue growing that business. And now we have a platform that lets us continually issue securitizations and stay balance sheet-light. We're earning fees — ongoing fees tied to those securitizations. I think that's going to start having a significant impact. In addition, even when we look at our GP/LP funds, we're seeing that fee structure really start to click in as well. Looking ahead to '27, I genuinely expect a meaningful percentage shift, and that isn't because Life Solutions will decline sharply. What's happening is that capital is beginning to flow in, both to our funds and to the securitizations, and that will generate additional fee-related earnings. What gets me more enthusiastic about '27, '28, '29, and '30 is the steadiness we now have. You've got the reliability of Life Solutions, and the other parts of fee-related earnings are finally producing results. The figures are climbing right before your eyes now. It's not just a target we're aiming for anymore—it's what's genuinely taking place—and we expect this to really begin unfolding in '27, which ought to deliver a solid, steady effect across '27 and '28.
Mike Grondahl
analystWith securitization at the size it reached and that third distribution channel now kind of unlocked, capital deployed for policy originations across the last 4 quarters is running a bit above $200 million. During the 5 quarters prior to that, it came in at just over $100 million, roughly $120 million per quarter. What's holding that figure back from climbing further and feeding the securitization engine?
Jay Jackson
executiveSure. Thanks, Mike. I appreciate that question. We give real thought to this: when capital deployed comes up, we're thinking about the securitizations. Elena mentioned it — not only duration matching but truly capital matching; and inventory is something we treat almost like a dial, and we adjust that dial relative to the capital on hand, since you never want to find yourself holding, A, too much inventory or, B, too little. So, since we're already planning for the securitizations coming up, I believe what you'll begin to see is a really efficient, steady flow of assets — meaning the balance sheet, as we satisfy the securitizations or as we satisfy some of the fund flows tied to both our interval fund and our private funds, you'll begin to see that origination flow rise. But your point is, can I then grow capital deployed 100% year-over-year? That doesn't strike me as realistic. Because capital won't grow 100% year-over-year or keep growing at 100%. Once we look at '27 and '28, I think you're going to see steady, highly targeted growth figures, and those will then line up with where capital deployed stands. So this year, I thought was — we're tracking, I believe, at 24% year-over-year on the guidance we just gave for Q4, at the top end of it. And looking at '27, we want to keep growing, but do it smartly so we can manage it and do it consistently.
Mike Grondahl
analystUnderstood; and as a quick follow-up on that. Do you happen to have, I'm not sure, some target range for the 1Q '27 securitization? Would that be no less than $400 million? Or what's your thinking on it at this point?
Jay Jackson
executiveCertainly. So what I mean is, when you look at our securitizations, and Elena I believe mentioned this, we're aiming for 2 or 3 more securitizations each year at roughly comparable size. But what we'd rather not do is state that it's definitely aimed at that figure, and then you — it comes in somewhat lower or higher depending on — and that isn't driven by demand. It's typically driven by portfolio construction, which means there's a particular kind of policy you need to have that fits really well inside that securitization. There's a specific sort of profile you want to have. And at times, you might use more smaller policies or more larger policies, and that could affect the dollar amount. But we're also focused on the number of lives that you have in there to provide a certain mix. And so, the dollar amount might be a range, but we're targeting a certain number of lives within those securitizations to ensure that you have proper diversification.
Dmitrii Primashov
analystNice work on those strong results. I'd like to ask about corporate debt. Your senior notes turn callable in February 2027. Are you planning to call them? If you do, should we expect you to redeem them using cash on hand, including securitization proceeds, or to refinance them with new debt? And on a broader level, do you have a target debt level? How are you thinking about the future level of debt?
Jay Jackson
executiveOkay. Yes. In terms of our capital and debt versus equity, we aim to use debt efficiently and in places where it can be accretive. So as we look at the debt you're referring to as the first stage of callable, all of those things are being taken into consideration by us. We wouldn't simply use cash to pay off debt. We would look at refinance and other scenarios; but when we look at that debt, it's also good debt. And so, that carries out another almost 1.5 years beyond its call date. So we have time. That's not a decision we need to make in Q1. As we look at where the balance sheet stands and its funding, we're comfortable with where the debt multiple sits relative to EBITDA. And there's potential room for us to have more debt to — and still stay within a very comfortable conservative range on our debt ratio relative to our EBITDA. So from our perspective, when we think about capital, whether debt or equity, it has to be accretive. And are we making investments that are accretive, meaning the underlying investments, are they accretive relative to the capital we're using? And I think we've answered that with — very effectively and with confidence that we are making decisions on the capital and the debt, and they are accretive; so that's the decision process we have when we think about debt just in general. And we're very comfortable with the debt we have, and we'll continue to keep a close eye on that. And if there are opportunities where there's — for strategic debt refinancing or other types of debt, we would take that into consideration based upon macro and market conditions.
Dmitrii Primashov
analystThen one more quick question about the Retirable tie-up. Overall, what kind of revenue effect are you anticipating from that?
Jay Jackson
executiveAbsolutely. Retirable stands out as a genuinely distinctive company, since what they do is essentially deliver financial services plus financial planning across many different account sizes, reaching as low as — their minimum is 0. As a result, quite often we see customers holding policies below $100,000 who may get a capital payment of $30,000 or $50,000, and they want to find out the smartest way to put that money to work. Plus they have an excellent AI-powered platform that is — together with actual advisers who made a strong impression on us — also leveraging our LifeARC program, in practice bringing in lifespan-based financial planning and assisting individuals in boosting their income and retirement. So the relationship has us enthusiastic; their team has us enthusiastic, and we believe this can be a multiyear partnership as time goes on.
Randy Binner
analystI joined a bit late, so I'm sorry if this has already been discussed, but 2 items on Slide 30 jump out at me. The gain is still — the realized gain is quite strong at mid-20s; and we — I believe we discuss this each quarter, yet it keeps coming in above 20%. In my mind that's sort of the long-term target, and that appears in some of the illustrations. So, just pausing there, I also want to ask about the turnover ratio; but will it drop under 20%? Or are we able to remain here at mid-20s? Because that makes a big difference in the model. It's clearly a great number, but I'm just trying to grasp how you're thinking about that as we go forward.
Jay Jackson
executiveOur approach is that we prefer to model and to think about our average realized gains conservatively. And what occurs is — with this number, if you consider it sitting above 20%, it's — as we keep capitalizing on more efficient cost of capital, we can sustain where that realized gain stands. And so, for the foreseeable future, we feel comfortable with the trend we've observed on realized gain. And yet if you go back to Q1 of '24, when it was nearest to 20%, you had a somewhat different rate environment. And I think it's worth taking into account the rate environment we are moving into as it relates to cost of capital. So I would suggest continuing to model the way we do, which is somewhat more conservatively, within that 20% range. And if it — if we end up somewhat higher than that, perhaps you can factor in a somewhat higher realized gain number. But I think that the conservative approach gives us somewhat more flexibility in relationship to short-term interest rate movements.
Randy Binner
analystOkay, that helps. And then, yes, about the turnover ratio rising past the band to 3x — that's clearly useful. And was there anything odd or one-off in there? Was it tied to securitization, so you're just rolling things over so fast?
Jay Jackson
executiveYes; so we — when you look at the point we closed the securitization, that was near the end of Q3. And several transactions happened in connection with the securitization right at the close of the quarter, and that pushed that multiple higher. That said, as we keep successfully issuing securitizations, which we believe we will, and we're aiming for another 2 to 3 in 2027, chances are we'll keep seeing a somewhat elevated turnover ratio, and whether it goes below 1.5, but perhaps near the top end of our 2x target.
Jay Jackson
executiveI appreciate everyone taking time from their day to join and listen in on today's call. And I hope you feel the same enthusiasm that we do, since every person in this room where we're sitting right now is a shareholder, and we're aligned with your thinking, your objectives, and how we view the road ahead. I believe this past quarter genuinely showed what we accomplished in terms of doing what we told you we would do. That matters a great deal — when you set out goals and targets and push the securitization over the finish line, and it wound up significantly oversubscribed, I think that's a strong sign of what lies ahead. And when you consider some of the recent choppiness driven by political factors or the change in control at the House and Congress, I'd simply point out to everyone that if you look at our underlying asset class, which has considerably less correlation to any other market, I think that's just such a crucial distinguishing characteristic when you're examining our business, correct? This is the kind of stretch when you get this volatility in which we usually see originations rise and we see capital flowing toward our kind of market and our kind of asset. And we believe that will keep going as we head into the new year; so thank you very much for your time and I look forward to speaking with you again soon.
Operator
operatorThanks — that takes us to the close of today's meeting. We appreciate the time you've given us and your participation. You're welcome to disconnect now.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Abacus Global Management, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Abacus Global Management, Inc. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Abacus Global Management, Inc. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.